STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave

STAT PlusNewsletterHealth Care Inc. Newsletter How $500 explains Republican health policy, and the GLP-1 Rx wave You’re reading STAT’s Health Care Inc. newsletter Manage alerts for this article Email this article Share this article By Bob HermanSept.

14, 2026 Business of Health Care Reporter Bob Herman[email protected]Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He is also the author of the Health Care Inc.

newsletter. You can reach Bob on Signal at bobjherman.09. This is the online version of STAT’s weekly email newsletter Health Care Inc.

Sign up here. There are two types of people: Those who have played RollerCoaster Tycoon, and those who haven’t. Nothing slaps like the original, but the upcoming reboot looks kinda cool.

Send me your roller coaster designs, or just say hi: [email protected].Advertisement Trump’s health policy: cash President Trump’s decision to funnel $500 checks to a specific subgroup of people with Affordable Care Act plans, right before the midterms, isn’t just another political quid pro quo. It captures the one loose health policy Republicans cling to: Let cash fix everything. STAT+ Exclusive Story Already have an account?

Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%!

Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In Congress, Donald Trump, drug development, government agencies, Health insurance, insurance, legal, Policy, STAT+ Submit a correction requestReprints Bob Herman Business of Health Care Reporter Bob covers the money in health care, focusing on health insurance and hospitals.

His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He is also the author of the Health Care Inc. newsletter.

You can reach Bob on Signal at bobjherman.09. Newsletter Unpacking the business — and secretive inner workings — of the U.S. health care industry Recommended The Readout September 14, 2026 STAT Plus: GSK touts lung cancer data from two drugs Unraveled September 14, 2026 The GOP’s $50 billion rural health fund is coming up short, hospital leaders say Advertisement The Readout September 11, 2026 STAT Plus: Cancer drug shortages keep disrupting patient care Politics September 10, 2026 STAT Plus: Right before midterms, Trump dangles $500 refunds for select ACA enrollees D.C.

Diagnosis September 10, 2026 STAT Plus: Can AI save rural health care? Subscriber Picks